AbCellera to Report First Quarter 2023 Financial Results on May 4, 2023
06 Aprile 2023 - 10:05PM
Business Wire
AbCellera (Nasdaq: ABCL) will announce its first quarter 2023
financial results on Thursday, May 4, 2023, and hold an earnings
conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time)
the same day.
A live audio webcast of the earnings conference may be accessed
through a link that will be posted on AbCellera’s Investor
Relations website. A replay will be available through the same link
following the conference call.
About AbCellera Biologics Inc.
AbCellera is breaking the barriers of conventional antibody drug
discovery to bring better medicines to patients, sooner.
AbCellera’s engine integrates expert teams, technology, and
facilities with the data science and automation needed to propel
antibody-based medicines from target to clinic in nearly every
therapeutic area with precision and speed. AbCellera provides
innovative biotechs and leading pharmaceutical companies with a
competitive advantage that empowers them to move quickly, reduce
cost, and tackle the toughest problems in drug development. For
more information, please visit www.abcellera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230404006025/en/
Inquiries Media: Jessica Yingling, Ph.D.;
media@abcellera.com, +1(236)521-6774 Business Development: Murray
McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005 Investor
Relations: Josephine Hellschlienger, Ph.D.; ir@abcellera.com,
+1(778)729-9116
Grafico Azioni AbCellera Biologics (NASDAQ:ABCL)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni AbCellera Biologics (NASDAQ:ABCL)
Storico
Da Lug 2023 a Lug 2024